Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression-Reference-Cited by-同舟云学术

Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression

Published:2023-05 Issue:5 Volume:41 Page:853-870.e13
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Jana Sujata,Brahma Sandipan,Arora Sonali,Wladyka Cynthia L.,Hoang Patrick,Blinka Steven,Hough Rowan,Horn Jessie L.,Liu Yuzhen,Wang Li-Jie,Depeille Philippe,Smith Eric,Montgomery Robert B.,Lee John K.,Haffner Michael C.,Vakar-Lopez Funda,Grivas Petros,Wright Jonathan L.,Lam Hung-Ming,Black Peter C.,Roose Jeroen P.,Ryazanov Alexey G.,Subramaniam Arvind R.,Henikoff Steven,Hsieh Andrew C.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference89 articles.

1. p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer;Marcel;Cancer Cell,2013

2. The translational landscape of mTOR signalling steers cancer initiation and metastasis;Hsieh;Nature,2012

3. mTORC1-mediated translational elongation limits intestinal tumour initiation and growth;Faller;Nature,2015

4. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation;Yang;Mol. Cell Biol.,2003

5. Arid1a has context-dependent oncogenic and tumor suppressor functions in liver cancer;Sun;Cancer Cell,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Caulerpa chemnitzia polysaccharide exerts immunomodulatory activity in macrophages by mediating the succinate/PHD2/HIF-1α/IL-1β pathway;International Journal of Biological Macromolecules;2024-10

2. Integrated analysis of patients with bladder cancer from prospective transcription factor activity: Implications for personalized treatment approaches;Methods;2024-10

3. Integrating frontiers: a holistic, quantum and evolutionary approach to conquering cancer through systems biology and multidisciplinary synergy;Frontiers in Oncology;2024-08-19

4. SMYD5 methylation of rpL40 links ribosomal output to gastric cancer;Nature;2024-07-24

5. Targeting a disintegrin and metalloprotease (ADAM) 17-CD122 axis enhances CD8+ T cell effector differentiation and anti-tumor immunity;Signal Transduction and Targeted Therapy;2024-06-26